Please activate JavaScript!
Please install Adobe Flash Player, click here for download
ePaper created 2014-09-15, 12:31:02 | version 1.32.01
Other transitions were also underway. Pieter G.M. van der Valk entered the department as an allergologist, starting the new day care unit and the in-patient department, while Elke G.J.M. de Jong took on the role of out-patient department head and developed a unit for skin and systemic diseases. In the seventies the concept of psoriasis had developed from a skin disease to a systemic disease involving the skin. Systemic treatments such as methotrexate, ciclosporin and etretinate were introduced. Photochemotherapy (PUVA) and high-dose phototherapy (UVB) were added in the treatment of psoriasis during the eighties. Research on the pathogenesis and therapeutic targets of psoriasis was initiated at the department at that time. Carine J.M. van der Vleuten took over the leadership of the working group on hemangioma and vascular malformations and consolidated a multidisciplinary team on the treatment of hemangiomas and vascular malformations. From 2004 onwards, Michelle M. van Rossum contributed by developing high standards of care and research for melanoma and lymphoma. Over the years the number of training positions for residents increased from 5 to 18. De Jong oversaw resident teaching for 15 years. Overseen by Prof. Dr. Joost Schalkwijk and Dr. Piet E.J. van Erp, the laboratories have always been located in close vicinity to the clinical care units. Such proximity between clinical and research units has allowed for ongoing translational collaborations. In 2012 a total of 10,262 new patients visited the out-patient department, while 2323 patients were treated in day care. Over the last decade, the number of in-patients has dropped, with only 135 recorded in 2012. 98 New dermatology building at the Radboud Campus. BWEADVSMGFINCORR:Opmaak 1 21-07-2014 17:40 Pagina 98